CLLS Stock Summary

• With a one year PEG ratio of 0.06, Cellectis SA is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than just 1.28% of US stocks.
• With a price/sales ratio of 32.23, Cellectis SA has a higher such ratio than 95.86% of stocks in our set.
• Over the past twelve months, CLLS has reported earnings growth of -14,354.35%, putting it ahead of just 0.14% of US stocks in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to Cellectis SA are EGAN, COG, COTY, LX, and RVLT.
• Visit CLLS's SEC page to see the company's official filings. To visit the company's web site, go to www.cellectis.com.